Michael Addition-Based Neoadjuvant for Enhanced Cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Michael Addition-Based Neoadjuvant for Enhanced Cancer Immunotherapy

Published:2024-07-25 Issue:31 Volume:18 Page:20806-20816
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Yang Ruoxi¹²,Di Yongxiang¹²,Song Xiaoning¹,Zhao Huimin¹,Cheng Yide¹,Lu Cunzhen¹,Yang Ying¹,Sun Minjie¹^ORCID,Zhou Zhanwei¹^ORCID

Affiliation:

1. NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, 24 TongJiaXiang, Nanjing 210009, China

2. Bioscience and Biomedical Engineering Thrust, The Hong Kong University of Science and Technology (Guangzhou), Guangzhou 511455, China

Funder

Jiangsu Provincial Key Research and Development Program

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c08014

Reference29 articles.

1. Injectable polypeptide hydrogel for dual-delivery of antigen and TLR3 agonist to modulate dendritic cells in vivo and enhance potent cytotoxic T-lymphocyte response against melanoma

2. Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti–PD-L1 to eliminate melanoma in mice

3. A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy

4. Leveraging Semiconducting Polymer Nanoparticles for Combination Cancer Immunotherapy

5. Nanoparticles with ultrasound-induced afterglow luminescence for tumour-specific theranostics

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP